TITLE

Kronik Hasta Servislerinde Uzun Süre Yatan Şizofreni Hastaları Nasıl Tedavi Ediliyor?

AUTHOR(S)
Kurt, Erhan; Özver, ‹smail; Alataş, Gazi; Bilgiç, Vedat
PUB. DATE
July 2010
SOURCE
Yeni Symposium;2010, Vol. 48 Issue 3, p223
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: With this study , the evaluation of their treatment of patients with schizophreniawho have been hospitalized for a long time in the chronic psychiatric patients services in Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery was aimed. Method: The medical records of 296 patients with schizophrenia in the chronic psychiatric inpatient units have been retrospectively and sociodemographic properties, antipsychotic prescriptions and medication combinations of these patients have been examined. Findings: The duration of hospitalization of the 296 patients with schizophrenia were ranging between 1 and 36 years (16.0±10.2 years). They were using 13 different antipsychotics prescribed as monotherapy or in combination with another antipsychotic. Among the atypical antipsychotics (AAPs) clozapine was the most preferred one whereas fluphenazine was the most prescribed among depot antipsychotics and haloperidol and chlorpromazine were the most used among classic antipsychotics (CAPs). Additionally 23 patients (7.8%) were not using any antipsychotic medications. Of the 273 patients who underwent antipsychotic medication, the 144 (48.8%) were taking antipsychotic monotherapy and 129 (43%) were on a combination therapy with two or more antipsychotic drugs. The most frequent combination in the latter group was haloperidol and chlorpromazine combination. It was also interesting that 29 patients (10%) were under triple antipsychotic medication. 42 patients (14%) were using depot antipsychotic in combination with AAPs or CAPs. 40 patients (13.5%) were using one or more CAPs or AAPs together whereas 209 patients (70.3%) were using one or more CAPs and 108 (36.5%) patients were using one or more AAPs. 49 (16.6%) patients were using mood stabilizers or anticonvulsants, 8 (2.7%) patients were using antidepressants, and 53 (17.9%) were using benzodiazepines whereas 209 (70.6%) patients were using anticholinergics. Discussion and Conclusion: The examination of the treatment regimens of the schizophrenic patients who have been hospitalized 16 years in average in the biggest and the oldest mental disorder hospital in our country provided us important data on this topic. Future researches as a continuum of this study are needed. Especially measuring the effects and the side effects of drugs and comparing CAPs and AAPs in respect to these measurements may provide more detailed data.
ACCESSION #
58649999

 

Related Articles

  • Use of Quetiapine to Manage Patients Who Experienced Adverse Effects with Clozapine. Reinstein, M.J.; Sonnenberg, J.G.; Mohan, S.C.; Chasanov, M.A.; Jones, L.E. // Clinical Drug Investigation;2003, Vol. 23 Issue 1, p63 

    Evaluates the efficacy of quetiapine for the treatment of schizophrenics experiencing the adverse effects of the antipsychotic drug clozapine. Administration of clozamine-quetiapine treatment to patients with significant signs of adverse effects; Side-effects of clozapine monotherapy; Absence of...

  • ¿Qué hacer cuando hay oposición médica al farmacéutico? (Caso de reinicio con clozapina). Bartoll Andrés, Adrián; Escoda Casanova, Juan Salvador; Pol Yanguas, Emilio // Farmacéuticos Comunitarios;2014, Vol. 6 Issue 1, p35 

    AB is a schizophrenic patient receiving clozapine. Following a series of problems with the medication, the patient had an episode of aggressiveness against his psychiatrist and nurse. The physician suspended clozapine, and after a period without the drug, he decided to reintroduce it at the...

  • New Pharmaceutical Strategies Devised in Effort to Treat Schizophrenia Effectively With Less Risk. Kleinerman, Matthew J. // JAMA: Journal of the American Medical Association;11/21/90, Vol. 264 Issue 19, p2487 

    Highlights antipsychotic drugs for schizophrenia. Properties of remoxipride; Treatment of schizophrenia using the combined neuroleptics and antidepressants; Benefits of clozapine.

  • Establishing cost-effectiveness of atypical neuroleptics. Robert, Glenn; Kennedy, Peter; Robert, G; Kennedy, P // British Journal of Psychiatry;Aug97, Vol. 171, p103 

    The article discusses a small-sample "before and after" cohort study of clozapine therapy which can provide a useful approach to handling costs when comparing treatments. The study showed that it is not difficult to obtain costing data. Evidence from 14 short-term double-blind comparisons showed...

  • Violent Behavior Variables Among Patients with Schizophrenia Under Forensic Psychiatric Process: A Case-Control Study. URAL, Cenk; ÖNCÜ, Fatih; BELLİ, Hasan; SOYSAL, Hüseyin // Turk Psikiyatri Dergisi;Spring2013, Vol. 24 Issue 1, p15 

    Objective: The aim of this study is to investigate the patterns of offense and treatment outcomes in patients with schizophrenia who have exhibited violent behavior and to provide data for mental health professionals to aid in the treatment and therapeutic support of schizophrenia patients....

  • Effects of Clozapine and Sulpiride on Morphine State-Dependent Memory in the Step-Down Passive Avoidance Test. Malekmohamadi, Nazanin; Heidari, Parviz; Sahebgharani, Mousa; Zarrindast, Mohammad-Reza // Pharmacology;2007, Vol. 79 Issue 3, p149 

    The effects of antipsychotic drugs sulpiride and clozapine on morphine state-dependent memory of passive avoidance task were examined in mice. Post-training administration of morphine (5 mg/kg) led to state-dependent learning with impaired memory retrieval on the test day which was reversed by...

  • Controversy Grows Over Monitoring System for New Schizophrenia Drug. Kleinerman, Matthew J. // JAMA: Journal of the American Medical Association;11/21/90, Vol. 264 Issue 19, p2488 

    Focuses on the controversy surrounding the use of antipsychotic drug clozapine for the treatment of schizophrenia. Therapeutic benefit of the drug to patients; Side effect of the drug; Lawsuits filed by mental health groups against U.S. states over the use of the drug; Criticism from the...

  • Satisfaction of hospitalized psychiatry patients: why should clinicians care? Zendjidjian, Xavier-Yves; Baumstarck, Karine; Auquier, Pascal; Loundou, Anderson; Lancon, Christophe; Boyer, Laurent // Patient Preference & Adherence;2014, Vol. 8, p575 

    Background: The aim of this study was to determine the relationship between inpatient satisfaction and health outcomes, quality of life, and adherence to treatment in a sample of patients with schizophrenia, while considering key sociodemographic and clinical confounding factors. Methods: This...

  • Prevalence and Correlates of Cigarette Smoking among Chinese Schizophrenia Inpatients Receiving Antipsychotic Mono-Therapy. Xu, Yan-Min; Chen, Hong-Hui; Li, Fu; Deng, Fang; Liu, Xiao-Bo; Yang, Hai-Chen; Qi, Li-Guo; Guo, Jin-Hong; Liu, Tie-Bang // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Objective: To investigate the prevalence rate of cigarette smoking and its socio-demographic and clinical correlates in Chinese schizophrenia inpatients receiving antipsychotic mono-therapy. Methods: This study was a cross-sectional, two-site, hospital-based survey. Four hundred and twenty-nine...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics